← Back

EMA - European Medicines Agency · EU-wide · 5 Sep 2025 · Administrative

PRAC meeting highlights, 1–4 September 2025

Original title: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025

From EMA - European Medicines Agency

Image credit: © tadamichi | stock.adobe.com

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025

PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections

NewsHumanPharmacovigilance

Excerpt from the official page. The original is authoritative.